Ticagrelor 90 mg is indicated for the prevention of thrombotic events (cardiovascular death, myocardial infarction, and stroke) in patients with Acute Coronary syndrome (ACS) - unstable angina, non-ST elevation Myocardial Infarction (NSTEMI) or ST elevation Myocardial Infarction (STEMI), including patients managed medically, and those who are managed with percutaneous coronary intervention (PCI) or coronary artery by-pass graft (CABG).